Author:
Teramoto Yoshiki,Akagawa Shohei,Hori Shin-ichiro,Tsuji Shoji,Higasa Koichiro,Kaneko Kazunari
Abstract
IntroductionGut microbial imbalance (dysbiosis) has been reported in patients with acute Kawasaki disease (KD). However, no studies have analyzed the gut microbiota while focusing on susceptibility to KD. This study aimed to evaluate whether dysbiosis elevates susceptibility to KD by assessing children with a history of KD. MethodsFecal DNA was extracted from 26 children with a history of KD approximately 1 year prior (KD group, 12 boys; median age, 32.5 months; median time from onset, 11.5 months) and 57 age-matched healthy controls (HC group, 35 boys; median age, 36.0 months). 16S rRNA gene analysis was conducted with the Illumina Miseq instrument. Sequence reads were analyzed using QIIME2.ResultsFor alpha diversity, Faith’s phylogenetic diversity was significantly higher in the KD group. Regarding beta diversity, the two groups formed significantly different clusters based on Bray–Curtis dissimilarity. Comparing microbial composition at the genus level, the KD and HC groups were significantly different in the abundance of two genera with abundance over 1% after Benjamini–Hochberg false discovery rate correction for multiple comparisons. Compared with the HC group, the KD group had higher relative abundance of Ruminococcus gnavus group and lower relative abundance of Blautia. Discussion and conclusionRuminococcus gnavus group reportedly includes pro-inflammatory bacteria. In contrast, Blautia suppresses inflammation via butyrate production. In the predictive functional analysis, the proportion of gut microbiota involved in several pathways was lower in the KD group. Therefore, dysbiosis characterized by distinct microbial diversity and decreased abundance of Blautia in parallel with increased abundance of Ruminococcus gnavus group might be a susceptibility factor for KD.
Funder
Japan Society for the Promotion of Science
Kansai Medical University
Subject
Immunology,Immunology and Allergy
Reference45 articles.
1. Kawasaki disease;Kawasaki;Proc Jpn Acad Ser B Phys Biol Sci,2006
2. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association;Newburger;Pediatrics,2004
3. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease;Fukazawa;Circ J,2020
4. Kawasaki disease: pathophysiology and insights from mouse models;Noval Rivas;Nat Rev Rheumatol,2020
5. Previous antibiotic use and the development of Kawasaki disease: a matched pair case-control study;Fukazawa;Pediatr Int,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献